BioinformaticsBioinformaticsPeer-reviewed journal article
PiDeel: Pathway-informed deep learning model for survivalanalysis and pathological classification of gliomas
Gün KaynariD, Doruk CakmakciiD, Caroline BundiD, Julien Todeschi, Izzie Jacques NameriD, A. Ercüment ÇiçekiD
Abstract
Online assessment of tumor characteristics during surgery is important and has the potential to establish an intraoperative surgeon feedback mechanism. With the availability of such feedback, surgeons could decide to be more liberal or conservative regarding the resection of the tumor. While there are methods to perform metabolomics-based online tumor pathology prediction, their model complexity and, in turn, the predictive performance is limited by the small dataset sizes. Furthermore, the information conveyed by the feedback provided on the tumor tissue could be improved both in terms of content and accuracy. In this study, we propose a metabolic pathway-informed deep learning model, PiDeeL, to perform survival analysis and pathology assessment based on metabolite concentrations. We show that incorporating pathway information into the model architecture substantially reduces parameter complexity and achieves better survival analysis and pathological classification performance. With these design decisions, we show that PiDeeL improves tumor pathology prediction performance of the state-of-the-art in terms of the Area Under the ROC Curve (AUC-ROC) by 3.38% and the Area Under the Precision-Recall Curve (AUC-PR) by 4.06%. Similarly, with respect to the time-dependent concordance index (c-index), we observe that PiDeeL achieves better survival analysis performance (improvement up to 4.3%) when compared to the state-of-the-art. Moreover, we show that importance analyses performed on input metabolite features as well as pathway-specific hidden-layer neurons of PiDeeL provide insights into tumor metabolism. We foresee that the use of this model in the surgery room will help surgeons adjust the surgery plan on the fly and will result in better prognosis estimates tailored to surgical procedures. AvailabilityThe code is released at https://github.com/ciceklab/PiDeeL. The data used in this study is released at https://zenodo.org/record/7228791. Contactcicek@cs.bilkent.edu.tr Supplementary informationSupplementary data are available at Briefings in Bioinformatics online.
- organism: human
- assay: metabolomics
- research focus: differential expression
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: deep learning
- Citations
- 9
- FWCI
- 0.80
- Field percentile
- top 33%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lilikoi V2.0: a deep-learning enabled, personalized pathway-based R package for diagnosis and prognosis predictions using metabolomics data
Xinying Fang, Yu Liu, … Lana Xia Garmire·GigaSciencePeer-reviewed·Jan 1, 2021
- Predicting cancer outcomes from histology and genomics using convolutional networks
Pooya Mobadersany, Safoora Yousefi, … Lee Cooper·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 12, 2018
- Fully Automated Brain Tumor Segmentation and Survival Prediction of Gliomas using Deep Learning and MRI
Chandan Ganesh Bangalore Yogananda, Ben C. Wagner, … Joseph A. Maldjian·Lecture notes in computer sciencePeer-reviewed·Jan 1, 2020
- Investigate the relevance of major signaling pathways in cancer survival using a biologically meaningful deep learning model
Jiarui Feng, Heming Zhang, Fuhai Li·BMC BioinformaticsPeer-reviewed·Feb 5, 2021
- Deep learning accurately predicts estrogen receptor status in breast cancer metabolomics data
Fadhl Alakwaa, Kumardeep Chaudhary, Lana Xia Garmire·Journal of Proteome ResearchPeer-reviewed·Nov 7, 2017
- Deep Learning Characterization of Brain Tumours With Diffusion Weighted Imaging
C. Meaney, S. Das, … M. Kohandel·bioRxiv·Jan 25, 2022